Trial Profile

Phase I-II clinical and pharmacokinetic study of irofulven in combination with oxaliplatin in patients with advanced solid tumours.

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 10 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Irofulven (Primary) ; Oxaliplatin (Primary)
Indications Endometrial cancer; Gastric cancer; Liver cancer; Pancreatic cancer; Solid tumours
Focus Therapeutic Use
Sponsors Eisai Inc

Most Recent Events

24 Nov 2021 Status changed from active, no longer recruiting to completed.
09 Mar 2009 Planned end date (Aug 2007) added as reported by ClinicalTrials.gov.
06 Mar 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 6 Mar 2009.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com